146 related articles for article (PubMed ID: 38170327)
1. Prediction of gastrointestinal symptoms trajectories using omega-3 and inflammatory biomarkers in early-stage breast cancer patients receiving chemotherapy.
Arcos D; Ng DQ; Ke Y; Toh YL; Chan A
Support Care Cancer; 2024 Jan; 32(1):76. PubMed ID: 38170327
[TBL] [Abstract][Full Text] [Related]
2. Effect of a 12-week integrative oncology intervention on gastro-intestinal concerns in patients with gynecological and breast cancer undergoing chemotherapy.
Shalom-Sharabi I; Keinan-Boker L; Samuels N; Lavie O; Lev E; Ben-Arye E
Med Oncol; 2017 Sep; 34(9):155. PubMed ID: 28779424
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
5. Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer.
Shalom-Sharabi I; Samuels N; Lavie O; Lev E; Keinan-Boker L; Schiff E; Ben-Arye E
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1243-1254. PubMed ID: 28247032
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract][Full Text] [Related]
7. Health Related Quality of Life (HRQoL) among Breast Cancer Patients Receiving Chemotherapy in Hospital Melaka: Single Centre Experience.
Chee Chean D; Kuo Zang W; Lim M; Zulkefle N
Asian Pac J Cancer Prev; 2016 Dec; 17(12):5121-5126. PubMed ID: 28122444
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes and correlation between symptoms and quality of life in patients with breast cancer during chemotherapy.
Wang YF; He RJ; Yuan XJ; Wang XM; Liang T; Cui ZQ; Liu JX
Technol Health Care; 2023; 31(4):1365-1373. PubMed ID: 36847033
[TBL] [Abstract][Full Text] [Related]
9. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
Kornblith AB; Lan L; Archer L; Partridge A; Kimmick G; Hudis C; Winer E; Casey R; Bennett S; Cohen HJ; Muss HB
J Clin Oncol; 2011 Mar; 29(8):1022-8. PubMed ID: 21300923
[TBL] [Abstract][Full Text] [Related]
10. [Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: a prospective study].
Liang XF; Ma DC; Ding ZY; Liu ZZ; Guo F; Liu L; Yu HY; Han YL; Xie XD
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):764-8. PubMed ID: 24378099
[TBL] [Abstract][Full Text] [Related]
11. Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population.
Grasic Kuhar C; Gortnar Cepeda T; Kurzeder C; Vetter M
Radiol Oncol; 2023 Jun; 57(2):211-219. PubMed ID: 37341200
[TBL] [Abstract][Full Text] [Related]
12. Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and Israel.
Mahtani R; Niyazov A; Arondekar B; Lewis K; Rider A; Massey L; Lux MP
BMC Cancer; 2022 Dec; 22(1):1343. PubMed ID: 36550413
[TBL] [Abstract][Full Text] [Related]
13. Alleviating gastro-intestinal symptoms and concerns by integrating patient-tailored complementary medicine in supportive cancer care.
Ben-Arye E; Aharonson ML; Schiff E; Samuels N
Clin Nutr; 2015 Dec; 34(6):1215-23. PubMed ID: 25556349
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.
Robson M; Ruddy KJ; Im SA; Senkus E; Xu B; Domchek SM; Masuda N; Li W; Tung N; Armstrong A; Delaloge S; Bannister W; Goessl C; Degboe A; Hettle R; Conte P
Eur J Cancer; 2019 Oct; 120():20-30. PubMed ID: 31446213
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy.
Sánchez-Lara K; Ugalde-Morales E; Motola-Kuba D; Green D
Br J Nutr; 2013 Mar; 109(5):894-7. PubMed ID: 22691288
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
Osoba D; Zee B; Pater J; Warr D; Kaizer L; Latreille J
Qual Life Res; 1994 Oct; 3(5):353-64. PubMed ID: 7841968
[TBL] [Abstract][Full Text] [Related]
17. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort study.
Toh YL; Tan CJ; Yeo AHL; Shwe M; Ho HK; Gan YX; Foo KM; Chu P; Olson K; Chan A
J Cell Mol Med; 2019 Jun; 23(6):4281-4289. PubMed ID: 31016867
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
Hassen AM; Taye G; Gizaw M; Hussien FM
PLoS One; 2019; 14(9):e0222629. PubMed ID: 31539399
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of EORTC QLQ-C30 questionnaire in patients undergoing in-hospital chemotherapy for gastrointestinal cancer in Japan.
Kato J; Nagahara A; Iijima K; Yoshimura M; Osada T; Yoshizawa T; Watanabe S
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S268-72. PubMed ID: 19120910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
